Got $5 to Spend on Penny Stocks? Check These 4 Out

4 Penny Stocks Under $5 to Watch in December 2021

Making a list of the best penny stocks to buy in December? Well, there are plenty of options to choose from. The first step as an investor is to understand what type of trader you are and what your tolerance for risk is. On one hand, we have those that choose to invest in the long-term time frame. This is not as common with penny stocks as they move very frequently.

Therefore, most investors tend to go with the second option, which is short-term or swing trading. This strategy is often used with small caps as volatility is a great principle for making short-term gains. Regardless, knowing which you are can easily mean the difference between profits and losses.

In addition to that, understanding what’s going on in the stock market and how to take advantage, will be a major benefit to you. Considering all of this, let’s take a look at four penny stocks to watch right now.

4 Penny Stocks For Your December 2021 Watchlist

Arbutus Biopharma Corp. (NASDAQ: ABUS)
Aprea Therapeutics Inc. (NASDAQ: APRE)
Meten Holding Group Ltd. (NASDAQ: METX)
Remark Holdings (NASDAQ: MARK)

Arbutus Biopharma Corporation (NASDAQ: ABUS)

Arbutus Biopharma is as its name suggests, a biotech company that has increased in value by around 3.2% in the past five days and almost 20% in the past month. If you’re not familiar, the company works on treatments for chronic illnesses such as Hepatitis B and coronaviruses. Arbutus’ main goal is to find, develop, and commercialize a diverse portfolio of assets with various modes of action in order to find a cure for those who have chronic hepatitis B virus (HBV) infections. The company’s partnership with Moderna has been one of its most successful ventures so far.

Earlier this month, Arbutus had a conversation with the United States Court Of Appeals For The Federal Circuit. This was in response to continuous disagreements with Moderna regarding Arbutus’ nucleic acid delivery lipid compositions. On December 7th, the company along with X-Chem and Proteros biostructures achieved its first milestone under its COVID-19 discovery research and license development. Arbutus has identified several molecules that could inhibit the growth of the COVID-19 virus. Arbutus obtained an exclusive license to these identified molecules.

“Our goal with this collaboration was to identify unique and differentiated pan-coronavirus assets targeting the main coronavirus protease which could deliver a much-needed oral antiviral treatment for SARS-CoV-2 and any potential future coronavirus outbreaks”.
The Chief Scientific Officer of Arbutus, Dr. Michael Sofia

With decent gains occurring throughout the past year, will ABUS be on your list of penny stocks to watch?

Aprea Therapeutics Inc. (NASDAQ: APRE)

Aprea Therapeutics, Inc. is a Boston, Massachusetts-based biopharmaceutical company that has climbed by more than 14% in the past five days. The company’s research facilities in Stockholm, Sweden, are dedicated to the development and commercialization of innovative cancer therapies that reactivate the mutant tumor suppressor protein p53. Eprenetapopt (APR-246), a small molecule under clinical development for hematologic malignancies and solid tumors, is the company’s principal product candidate.

On December 9th, Aprea announced the removal of a U.S. Food and Drug Administration clinical hold on its trial of Eprenetapopt in Lymphoid Malignancies. This hold was related to the use of eprenetapopt with acalabrutinib or venetoclax and rituximab, and is now offering positive news for the company.

“We are pleased to have addressed the FDA’s concerns and receive clearance to proceed with future clinical study of eprenetapopt in non-Hodgkin’s lymphomas. We look forward to continued evaluation of eprenetapopt as a therapeutic option for these patients with unmet medical need.”
The Chief Medical Officer of Aprea, Eyal Attar, M.D.

Amid new developments, APRE stock has made some significant gains in the past few trading days. Noting this, will APRE be on your list of penny stocks to watch?

Meten Holding Group Ltd. (NASDAQ: METX)

Meten Holding Group Ltd., formerly Meten EdtechX Education Group Ltd., is a Chinese provider of various English language training courses and services. This company provides a variety of skill training products to Chinese students and professionals. Its services are offered under the ABC, Meten, and Likeshuo brand names. These products offer high teaching quality and student satisfaction using cutting-edge technology such as AI-driven centralized teaching and more.

On November 22nd, the company released its financial results for the third quarter of 2021. Meten’s revenue declined 36.9% year over year in the third quarter due to lower gross billings. The company’s gross profit margin fell 8.2% to 34.1% in total. In this quarter, Meten’s overall adjusted net loss increased 364.8% year over year. While these results are nothing to write home about, they do make sense given the regulatory situations surrounding for-profit tutoring in China. As a result, companies like METX have seen major declines in revenue in the past few months.

“In the third quarter of 2021, we have significantly reduced the number of our offline learning centers to effectively reduce the impact of the resurgence of the Covid-19 pandemic on our offline business operations, improve resource utilization, and prepare for the Company’s business transformation.”
The CEO of Meten, Alan Peng

Meten Holding Group operates 64 learning facilities as of September 30, 2021. By the end of the third quarter of 2021, the company announced the closure of 38 offline learning facilities to improve its financial situation. Moving forward it will be interesting to see how METX performs going into 2022. For now, will METX stock be on your penny stocks watchlist during the rest of 2021?

Remark Holdings Inc. (NASDAQ: MARK)

Remark Holdings is a penny stock that has climbed by almost 10% in the past five days. If you’re not familiar, Remark is an artificial intelligence-focused company that creates and deploys solutions for businesses and software developers. The company’s AI tools are being used in a variety of areas including retail, finance, public safety, and the workplace. In addition, the company owns and runs digital media properties that provide relevant, dynamic content as well as e-commerce solutions.

Remark revealed its third-quarter financial figures for 2021 on November 15th. During this time, the company obtained a $5 million contract to provide AI workplace safety solutions to 100 industrial real estate construction sites. Remark’s revenue was $1.2 million in FYQ3 2021, compared to $2.6 million in FYQ3 2020. The company’s gross profit declined from $1 million in 2020 to $0.4 million in 2021

“Despite stringent, periodic citywide lockdowns associated with COVID-19 in China and a major U.S. customer slowing its product rollout due to technical difficulties, we have been able to achieve revenue through the first nine months of 2021 of $9.7 million, nearly matching full year 2020 revenue of $10.1 million.”
Chairman and CEO of Remark Holdings, Kai-Shing Tao

On December 6th, Remark announced a $30 million debt financing deal with Mudrick Capital Management, L.P. The funds will be used to make payments on its debts and liabilities, provide working capital for existing projects, and fund new business initiatives, such as opportunities in infrastructure, security, and data analytics, as well as invest in and build NFT and metaverse enterprises. Noting all of this new info, will MARK be on your list of penny stocks to watch?

Are Penny Stocks Worth Buying Right Now?

If you’re looking for the best penny stocks to buy right now, there are hundreds of options to choose from. However, it’s not as easy as picking a few stocks and adding them to your watchlist.

Rather, investors need to have a full understanding of which penny stocks are worth it and how to take advantage. Considering all of this, do you think that penny stocks are worth buying right now or not?

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!

Sign up for our FREE Newsletter and get: